Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Neoplasms of the CNS

Free Subscription Articles published in Int J Cancer Retrieve available abstracts of 73 articles: HTML format

Single Articles

September 2024
1. EHRET F, Ruess D, Blanck O, Fichte S, et al
   Stereotactic radiosurgery and radiotherapy for brainstem metastases: An international multicenter analysis.
   Int J Cancer. 2024;155:916-924.
   PubMed     Abstract available
   
   
   July 2024
2. ZHANG Q, Chen K, Yu X, Fan Y, et al
   Spotlight on the treatment of non-small cell lung cancer with rare genetic alterations and brain metastasis: Current status and future perspectives.
   Int J Cancer. 2024 Jul 3. doi: 10.1002/ijc.35070.
   PubMed     Abstract available
   
   
   
3. REN P, Bao H, Wang S, Wang Y, et al
   Multi-scale brain attributes contribute to the distribution of diffuse glioma subtypes.
   Int J Cancer. 2024 Jul 1. doi: 10.1002/ijc.35068.
   PubMed     Abstract available
   
   
   June 2024
4. KNABBE J, Kowalski T, Seliger C
   Pharmacological treatment of depression in patients with brain tumors.
   Int J Cancer. 2024 Jun 28. doi: 10.1002/ijc.35058.
   PubMed     Abstract available
   
   
   
5. GANSER K, Stransky N, Abed T, Quintanilla-Martinez L, et al
   K(Ca) channel targeting impairs DNA repair and invasiveness of patient-derived glioblastoma stem cells in culture and orthotopic mouse xenografts which only in part is predictable by K(Ca) expression levels.
   Int J Cancer. 2024 Jun 27. doi: 10.1002/ijc.35064.
   PubMed     Abstract available
   
   
   
6. 
   Correction to "Inhibition of phosphatidylinositol 3-kinase signaling negates the growth advantage imparted by a mutant epidermal growth factor receptor on human glioblastoma cells".
   Int J Cancer. 2024 Jun 11. doi: 10.1002/ijc.35045.
   PubMed    
   
   
   May 2024
7. 
   Correction to "Therapeutic targeting of chemoresistant and recurrent glioblastoma stem cells with a proapoptotic variant of oncolytic herpes simplex virus".
   Int J Cancer. 2024 May 21. doi: 10.1002/ijc.35002.
   PubMed    
   
   
   
8. 
   Expression of Concern: Nusrat Jahan, Jae M. Lee, Khalid Shah, Hiroaki Wakimoto (2017), Therapeutic targeting of chemoresistant and recurrent glioblastoma stem cells with a proapoptotic variant of oncolytic herpes simplex virus. Int. J. Cancer, 141: 16
   Int J Cancer. 2024 May 21. doi: 10.1002/ijc.35032.
   PubMed     Abstract available
   
   
   
9. MEENA D, Jha S
   Autophagy in glioblastoma: A mechanistic perspective.
   Int J Cancer. 2024 May 8. doi: 10.1002/ijc.34991.
   PubMed     Abstract available
   
   
   
10. DERKS SHAE, van der Meer EL, Joosse A, de Jonge MJA, et al
    The development of brain metastases in patients with different therapeutic strategies for metastatic renal cell cancer.
    Int J Cancer. 2024 May 4. doi: 10.1002/ijc.34984.
    PubMed     Abstract available
    
    
    April 2024
11. WEIJERS DD, Hirsch S, Bakhuizen JJ, van Engelen N, et al
    Molecular analysis of cancer genomes in children with Lynch syndrome: Exploring causal associations.
    Int J Cancer. 2024;154:1455-1463.
    PubMed     Abstract available
    
    
    
12. O'NEILL K, Syed N, Crook T, Dubey S, et al
    Profiling of circulating glial cells for accurate blood-based diagnosis of glial malignancies.
    Int J Cancer. 2024;154:1298-1308.
    PubMed     Abstract available
    
    
    February 2024
13. XI S, Jiang S, Li H, Huang Q, et al
    Adult epithelioid glioblastoma exhibits an extremely poor prognosis and high frequency of SWI/SNF complex mutation: Insights from a retrospective study.
    Int J Cancer. 2024 Feb 27. doi: 10.1002/ijc.34854.
    PubMed     Abstract available
    
    
    
14. CHELLADURAI M, Xu D, Izraely S, Ben-Menachem S, et al
    A heterodimer of alpha and beta hemoglobin chains functions as an innate anticancer agent.
    Int J Cancer. 2024;154:561-572.
    PubMed     Abstract available
    
    
    January 2024
15. KEMMOTSU N, Ninomiya K, Kunimasa K, Ishino T, et al
    Low frequency of intracranial progression in advanced NSCLC patients treated with cancer immunotherapies.
    Int J Cancer. 2024;154:169-179.
    PubMed     Abstract available
    
    
    
16. HOANG TT, Schraw JM, Peckham-Gregory EC, Scheurer ME, et al
    Fetal growth and pediatric cancer: A pan-cancer analysis in 7000 cases and 37 000 controls.
    Int J Cancer. 2024;154:41-52.
    PubMed     Abstract available
    
    
    December 2023
17. MENTIS AA, Papavassiliou KA, Piperi C, Papavassiliou AG, et al
    How can cancer research be illuminated by brain research (and vice versa)?
    Int J Cancer. 2023;153:1967-1970.
    PubMed     Abstract available
    
    
    October 2023
18. LARSEN PA, Amidi A, Ghith N, Winther JF, et al
    Quality of life of adolescent and adult survivors of childhood cancer in Europe-A systematic review.
    Int J Cancer. 2023;153:1356-1375.
    PubMed     Abstract available
    
    
    September 2023
19. SIRIRUNGREUNG A, Hansen J, Ritz B, Heck JE, et al
    Association between medically diagnosed postnatal infection and childhood cancers: A matched case-control study in Denmark, 1978 to 2016.
    Int J Cancer. 2023;153:994-1002.
    PubMed     Abstract available
    
    
    July 2023
20. PROKOP G, Wiestler B, Hieber D, Withake F, et al
    Multiscale quantification of morphological heterogeneity with creation of a predictor of longer survival in glioblastoma.
    Int J Cancer. 2023 Jul 28. doi: 10.1002/ijc.34665.
    PubMed     Abstract available
    
    
    June 2023
21. GIELNIEWSKI B, Poleszak K, Roura AJ, Szadkowska P, et al
    Targeted sequencing of cancer-related genes reveals a recurrent TOP2A variant which affects DNA binding and coincides with global transcriptional changes in glioblastoma.
    Int J Cancer. 2023 Jun 20. doi: 10.1002/ijc.34631.
    PubMed     Abstract available
    
    
    
22. TSAKONAS G, Ekman S, Koulouris A, Adderley H, et al
    Safety and efficacy of immune checkpoint blockade in patients with advanced nonsmall cell lung cancer and brain metastasis.
    Int J Cancer. 2023 Jun 19. doi: 10.1002/ijc.34628.
    PubMed     Abstract available
    
    
    
23. WEISS S, Thomale UW, Schulz M, Kandels D, et al
    Neurosurgical morbidity in pediatric supratentorial midline low-grade glioma: Results from the German LGG studies.
    Int J Cancer. 2023 Jun 1. doi: 10.1002/ijc.34615.
    PubMed     Abstract available
    
    
    May 2023
24. ESLIN D, Zage PE, Bergendahl G, Lewis E, et al
    A phase II trial of nifurtimox combined with topotecan and cyclophosphamide for refractory or relapsed neuroblastoma and medulloblastoma.
    Int J Cancer. 2023 May 29. doi: 10.1002/ijc.34569.
    PubMed     Abstract available
    
    
    
25. OFEK P, Yeini E, Arad G, Danilevsky A, et al
    Deoxyhypusine hydroxylase: A novel therapeutic target differentially expressed in short-term vs long-term survivors of glioblastoma.
    Int J Cancer. 2023 May 4. doi: 10.1002/ijc.34545.
    PubMed     Abstract available
    
    
    April 2023
26. KANNAN S, Cheng VWT
    Nanoparticle drug delivery to target breast cancer brain metastasis: Current and future trends.
    Int J Cancer. 2023 Apr 25. doi: 10.1002/ijc.34542.
    PubMed     Abstract available
    
    
    March 2023
27. BAO H, Ren P, Liang P, Liang X, et al
    Reply to: Comments on "New insights into glioma frequency maps: From genetic and transcriptomic correlate to survival prediction".
    Int J Cancer. 2023 Mar 17. doi: 10.1002/ijc.34514.
    PubMed    
    
    
    
28. SABOUR S, Ghassemi F
    Comments on "New insights into glioma frequency maps: From genetic and transcriptomic correlate to survival prediction".
    Int J Cancer. 2023 Mar 17. doi: 10.1002/ijc.34515.
    PubMed    
    
    
    
29. YANG W, Zhao X, Zheng A, Liu Z, et al
    Identification of MET fusions in solid tumors: A multicenter, large scale study in China.
    Int J Cancer. 2023;152:1259-1268.
    PubMed     Abstract available
    
    
    January 2023
30. SCHERM A, Ippen FM, Hau P, Baurecht H, et al
    Targeted therapies in patients with newly diagnosed glioblastoma - a systematic meta-analysis of randomized clinical trials.
    Int J Cancer. 2023 Jan 16. doi: 10.1002/ijc.34433.
    PubMed     Abstract available
    
    
    December 2022
31. ZHANG S, Zhang J, Hu X, Yin S, et al
    Non-invasive Detection of Brain Gliomas Using Plasma Cell-free DNA 5-Hydroxymethylcytosine Sequencing.
    Int J Cancer. 2022 Dec 15. doi: 10.1002/ijc.34401.
    PubMed     Abstract available
    
    
    
32. GORODEZKI D, Zipfel J, Queudeville M, Holzer U, et al
    Evaluating the safety of perioperative dexamethasone treatment: A retrospective analysis of a single center pediatric low-grade glioma cohort.
    Int J Cancer. 2022 Dec 15. doi: 10.1002/ijc.34399.
    PubMed     Abstract available
    
    
    
33. MONTELLA L, Cuomo M, Del Gaudio N, Buonaiuto M, et al
    Epigenetic alterations in glioblastomas: diagnostic, prognostic and therapeutic relevance.
    Int J Cancer. 2022 Dec 7. doi: 10.1002/ijc.34381.
    PubMed     Abstract available
    
    
    November 2022
34. PETIT P, Gandon G, Chabardes S, Bonneterre V, et al
    Agricultural activities and risk of central nervous system tumors among French farm managers: Results from the TRACTOR project.
    Int J Cancer. 2022;151:1737-1749.
    PubMed     Abstract available
    
    
    
35. SELIGER C, Oppong FB, Lefranc F, Chinot O, et al
    Research Article: Association of antidepressant drug use with outcome of patients with glioblastoma.
    Int J Cancer. 2022 Nov 8. doi: 10.1002/ijc.34344.
    PubMed     Abstract available
    
    
    October 2022
36. BAO H, Ren P, Yi L, Lv Z, et al
    New Insights into Glioma Frequency Maps: From Genetic and Transcriptomic Correlate to Survival Prediction.
    Int J Cancer. 2022 Oct 28. doi: 10.1002/ijc.34336.
    PubMed     Abstract available
    
    
    
37. KHAN AB, Lee S, Serin Harmanci A, Patel R, et al
    Cxcr4 Expression is Associated with Proneural-To-Mesenchymal Transition in Glioblastoma.
    Int J Cancer. 2022 Oct 17. doi: 10.1002/ijc.34329.
    PubMed     Abstract available
    
    
    September 2022
38. MAGRI S, Musca B, Pinton L, Orecchini E, et al
    The immunosuppression pathway of tumor-associated macrophages is controlled by heme oxygenase-1 in glioblastoma patients.
    Int J Cancer. 2022 Sep 2. doi: 10.1002/ijc.34270.
    PubMed     Abstract available
    
    
    August 2022
39. TZARIDIS T, Weller J, Bachurski D, Shakeri F, et al
    "A novel serum extracellular vesicle protein signature to monitor glioblastoma tumor progression".
    Int J Cancer. 2022 Aug 27. doi: 10.1002/ijc.34261.
    PubMed     Abstract available
    
    
    
40. KHALID U, Simovic M, Hammann LA, Iskar M, et al
    A synergistic interaction between HDAC- and PARP inhibitors in childhood tumors with chromothripsis.
    Int J Cancer. 2022;151:590-606.
    PubMed     Abstract available
    
    
    July 2022
41. CAO J, Yan W, Li G, Zhan Z, et al
    Incidence and Survival of Benign, Borderline, and Malignant Meningioma Patients in the United States from 2004 to 2018.
    Int J Cancer. 2022 Jul 2. doi: 10.1002/ijc.34198.
    PubMed     Abstract available
    
    
    
42. SOLOMON A, Alteber Z, Bassan D, Sharbi-Yunger A, et al
    On the development of a neoantigen vaccine for the prevention of Lynch Syndrome.
    Int J Cancer. 2022;151:107-119.
    PubMed     Abstract available
    
    
    June 2022
43. ATWAL A, Snowsill T, Dandy MC, Krum T, et al
    The prevalence of mismatch repair deficiency in ovarian cancer: A systematic review and meta-analysis.
    Int J Cancer. 2022 Jun 15. doi: 10.1002/ijc.34165.
    PubMed     Abstract available
    
    
    May 2022
44. VON KNEBEL DOEBERITZ N, Paech D, Sturm D, Pusch S, et al
    Changing paradigms in oncology: toward non-cytotoxic treatments for advanced gliomas.
    Int J Cancer. 2022 May 23. doi: 10.1002/ijc.34131.
    PubMed     Abstract available
    
    
    
45. SU C, Zhou J, Qiang H, Zhao J, et al
    Special issue "The advance of solid tumor research in China": Real-world clinical outcomes of alectinib for advanced non-small-cell lung cancer patients with ALK fusion in China.
    Int J Cancer. 2022 May 17. doi: 10.1002/ijc.34123.
    PubMed     Abstract available
    
    
    February 2022
46. COGHILL AE, Kim Y, Hodge JM, Bender N, et al
    Prospective investigation of herpesvirus infection and risk of glioma.
    Int J Cancer. 2022 Feb 28. doi: 10.1002/ijc.33987.
    PubMed     Abstract available
    
    
    
47. PETROSYAN E, Fares J, Cordero A, Rashidi A, et al
    Repurposing Autophagy Regulators in Brain Tumors.
    Int J Cancer. 2022 Feb 18. doi: 10.1002/ijc.33965.
    PubMed     Abstract available
    
    
    January 2022
48. GANSER K, Eckert F, Riedel A, Stransky N, et al
    Patient-individual phenotypes of glioblastoma stem cells are conserved in culture and associate with radioresistance, brain infiltration and patient prognosis.
    Int J Cancer. 2022 Jan 27. doi: 10.1002/ijc.33950.
    PubMed     Abstract available
    
    
    December 2021
49. ZHAO Y, Li S, Yang X, Chu L, et al
    Overall survival benefit of Osimertinib and clinical value of upfront cranial local therapy in untreated EGFR-mutant non-small cell lung cancer with brain metastasis.
    Int J Cancer. 2021 Dec 16. doi: 10.1002/ijc.33904.
    PubMed     Abstract available
    
    
    September 2021
50. CHENG S, McLaughlin JR, Brown MC, Al-Sawaihey H, et al
    Childhood head trauma and the risk of childhood brain tumours: a case-control study in Ontario, Canada.
    Int J Cancer. 2021 Sep 14. doi: 10.1002/ijc.33805.
    PubMed     Abstract available
    
    
    August 2021
51. CHATTERJEE D, Chakrabarti O
    Role of stress granules in modulating senescence and promoting cancer progression: special emphasis on glioma.
    Int J Cancer. 2021 Aug 30. doi: 10.1002/ijc.33787.
    PubMed     Abstract available
    
    
    July 2021
52. LI N, Shi H, Hou P, Gao L, et al
    Genetic variants of CYP4F12 gene are associated with glioma susceptibility.
    Int J Cancer. 2021 Jul 28. doi: 10.1002/ijc.33755.
    PubMed     Abstract available
    
    
    
53. LAN C, Li H, Wang L, Zhang J, et al
    Absolute Quantification of 2-Hydroxyglutarate on Tissue by MALDI MSI for Rapid and Precise Identification of IDH Mutations in Human Glioma.
    Int J Cancer. 2021 Jul 5. doi: 10.1002/ijc.33729.
    PubMed     Abstract available
    
    
    
54. DARLIX A, Hirtz C, Mollevi C, Ginestet N, et al
    Serum GFAP is a predictor of brain metastases in patients with metastatic breast cancer.
    Int J Cancer. 2021 Jul 1. doi: 10.1002/ijc.33724.
    PubMed     Abstract available
    
    
    
55. LIU C, Huang B, Wu R, Chen J, et al
    Adequate asparaginase is important to prevent central nervous system and testicular relapse of pediatric Philadelphia chromosome-negative B-cell acute lymphoblastic leukemia.
    Int J Cancer. 2021;149:158-168.
    PubMed     Abstract available
    
    
    May 2021
56. YU X, Sheng J, Pan G, Fan Y, et al
    Real-World Utilization of EGFR TKIs and Prognostic Factors for Survival in EGFR-Mutated Non-Small Cell Lung Cancer Patients with Brain Metastases.
    Int J Cancer. 2021 May 10. doi: 10.1002/ijc.33677.
    PubMed     Abstract available
    
    
    
57. HUANG W, Sundquist K, Sundquist J, Ji J, et al
    Risk of somatic diseases in offspring of survivors with childhood or adolescent central nervous system tumor in Sweden.
    Int J Cancer. 2021;148:2184-2192.
    PubMed     Abstract available
    
    
    April 2021
58. TZARIDIS T, Schafer N, Weller J, Steinbach JP, et al
    MGMT promoter methylation analysis for allocating combined CCNU/TMZ chemotherapy: Lessons learned from the CeTeG/NOA-09 trial.
    Int J Cancer. 2021;148:1695-1707.
    PubMed     Abstract available
    
    
    
59. SOLIMAN RM, Elhaddad A, Oke J, Eweida W, et al
    Temporal trends in childhood cancer survival in Egypt, 2007 to 2017: A large retrospective study of 14 808 children with cancer from the Children's Cancer Hospital Egypt.
    Int J Cancer. 2021;148:1562-1574.
    PubMed     Abstract available
    
    
    February 2021
60. REULEN RC, Guha J, Bright CJ, Henson KE, et al
    Risk of cerebrovascular disease among 13 457 five-year survivors of childhood cancer: A population-based cohort study.
    Int J Cancer. 2021;148:572-583.
    PubMed     Abstract available
    
    
    January 2021
61. OKAMURA R, Piccioni DE, Boichard A, Lee S, et al
    High Prevalence of Clonal Hematopoiesis-type Genomic Abnormalities in Cell-free DNA in Invasive Gliomas After Treatment.
    Int J Cancer. 2021 Jan 26. doi: 10.1002/ijc.33481.
    PubMed     Abstract available
    
    
    
62. HODGE JM, Coghill AE, Kim Y, Bender N, et al
    Toxoplasma gondii infection and the risk of adult glioma in two prospective studies.
    Int J Cancer. 2021 Jan 11. doi: 10.1002/ijc.33443.
    PubMed     Abstract available
    
    
    December 2020
63. CACCHIONE A, Lodi M, Carai A, Miele E, et al
    Upfront treatment with mTOR inhibitor everolimus in pediatric Low-Grade gliomas: A Single Center Experience.
    Int J Cancer. 2020 Dec 15. doi: 10.1002/ijc.33438.
    PubMed     Abstract available
    
    
    
64. BOGNER EM, Daly AF, Gulde S, Karhu A, et al
    miR-34a is upregulated in AIP-mutated somatotropinomas and promotes octreotide resistance.
    Int J Cancer. 2020;147:3523-3538.
    PubMed     Abstract available
    
    
    
65. JUNG E, Alfonso J, Monyer H, Wick W, et al
    Neuronal signatures in cancer.
    Int J Cancer. 2020;147:3281-3291.
    PubMed     Abstract available
    
    
    November 2020
66. HUANG W, Sundquist K, Sundquist J, Ji J, et al
    Poor academic performance in offspring of survivors with childhood or adolescent central nervous system tumor in Sweden.
    Int J Cancer. 2020;147:2687-2694.
    PubMed     Abstract available
    
    
    October 2020
67. THURMAIER J, Heinemann V, Engel J, Schubert-Fritschle G, et al
    Patients with colorectal cancer and brain metastasis: The relevance of extracranial metastatic patterns predicting time intervals to first occurrence of intracranial metastasis and survival.
    Int J Cancer. 2020 Oct 28. doi: 10.1002/ijc.33364.
    PubMed     Abstract available
    
    
    September 2020
68. KARALEXI MA, Dessypris N, Georgakis MK, Ryzhov A, et al
    Birth seasonality of childhood central nervous system tumors: Analysis of primary data from 16 Southern-Eastern European population-based registries.
    Int J Cancer. 2020;147:1252-1263.
    PubMed     Abstract available
    
    
    August 2020
69. HE JB, Zhang X, Guo ZW, Liu MM, et al
    Ponatinib therapy in recurrent Philadelphia chromosome-positive central nervous system leukemia with T315I mutation after Allo-HSCT.
    Int J Cancer. 2020;147:1071-1077.
    PubMed     Abstract available
    
    
    
70. GAO C, Wang F, Suki D, Strom E, et al
    Effects of systemic therapy and local therapy on outcomes of 873 breast cancer patients with metastatic breast cancer to brain: MD Anderson Cancer Center experience.
    Int J Cancer. 2020 Aug 4. doi: 10.1002/ijc.33243.
    PubMed     Abstract available
    
    
    July 2020
71. HUANG W, Sundquist K, Sundquist J, Crump C, et al
    Risk of being born preterm in offspring of survivors with childhood or adolescent central nervous system tumor in Sweden.
    Int J Cancer. 2020;147:100-106.
    PubMed     Abstract available
    
    
    June 2020
72. LAN B, Abudureheiyimu N, Zhang J, Wang C, et al
    Clinical features and prognostic factors for extracranial oligometastatic breast cancer in China.
    Int J Cancer. 2020 Jun 14. doi: 10.1002/ijc.33152.
    PubMed     Abstract available
    
    
    October 2019
73. BLAZQUEZ R, Rietkotter E, Wenske B, Wlochowitz D, et al
    LEF1 supports metastatic brain colonization by regulating glutathione metabolism and increasing ROS resistance in breast cancer.
    Int J Cancer. 2019 Oct 18. doi: 10.1002/ijc.32742.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Neoplasms of the CNS is free of charge.